|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,854 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,066,843 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,387 |
|
|
Total
Value |
$65,005,693 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-13.1%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
852 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 9 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-04-06 |
4 |
OE |
$14.39 |
$21,585 |
D/D |
1,500 |
395,221 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2020-06-30 |
4 |
A |
$103.97 |
$21,626 |
D/D |
208 |
9,190 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-07-03 |
4 |
AB |
$14.44 |
$21,660 |
D/D |
1,500 |
29,381 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-08-01 |
4 |
AB |
$14.50 |
$21,750 |
D/D |
1,500 |
30,881 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2009-06-12 |
4 |
B |
$14.52 |
$21,780 |
D/D |
1,500 |
51,940 |
2.81 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2014-05-16 |
4 |
S |
$22.03 |
$22,030 |
D/D |
(1,000) |
706 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-09-08 |
4 |
S |
$22.22 |
$22,220 |
D/D |
(1,000) |
95,067 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2020-09-30 |
4 |
A |
$89.74 |
$22,794 |
D/D |
254 |
9,444 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-04-28 |
4 |
A |
$6.92 |
$23,393 |
D/D |
3,381 |
21,881 |
|
- |
|
INCY |
Incyte Corp |
Director |
|
2020-12-31 |
4 |
A |
$86.98 |
$23,920 |
D/D |
275 |
8,921 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-05-02 |
4 |
AS |
$16.36 |
$24,647 |
D/D |
(1,500) |
15,142 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-03-02 |
4 |
AS |
$16.44 |
$24,723 |
D/D |
(1,500) |
18,142 |
0 |
- |
|
IMUX |
Immunic Inc |
Director |
|
2015-09-09 |
4 |
B |
$3.07 |
$24,800 |
D/D |
8,000 |
33,119 |
2.39 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2014-03-06 |
4 |
S |
$25.15 |
$25,150 |
D/D |
(1,000) |
1,706 |
0 |
- |
|
ITMN |
InterMune Inc |
Director |
|
2012-06-04 |
4 |
A |
$10.10 |
$25,250 |
D/D |
2,500 |
6,725 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-03-04 |
4 |
OE |
$6.46 |
$25,840 |
D/D |
4,000 |
31,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-11-03 |
4 |
OE |
$6.46 |
$25,840 |
D/D |
4,000 |
97,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-02 |
4 |
OE |
$6.46 |
$25,840 |
D/D |
4,000 |
135,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-02-04 |
4 |
OE |
$12.99 |
$25,980 |
D/D |
2,000 |
155,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-02 |
4 |
OE |
$12.99 |
$25,980 |
I/I |
2,000 |
15,545 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-21 |
4 |
OE |
$12.99 |
$25,980 |
I/I |
2,000 |
32,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-09-16 |
4 |
OE |
$12.99 |
$25,980 |
I/I |
2,000 |
50,740 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-10-16 |
4 |
OE |
$12.99 |
$25,980 |
I/I |
2,000 |
47,740 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-03-28 |
4 |
OE |
$12.99 |
$25,980 |
I/I |
2,000 |
48,740 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-10-21 |
4 |
OE |
$12.99 |
$25,980 |
I/I |
2,000 |
48,195 |
0 |
- |
|
852 Records found
|
|
Page 9 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|